Report this

Tell us if this breaks our content standards or is wrong. An editor reviews every report. Reports don't remove anything automatically.

Sponsored law allowing some stem cell therapies not FDA-approved

Prime sponsor of HB2246 in the 114th General Assembly (2025-2026). Enacted; parts took effect May 19 and July 1, 2026. The treatment must be within the physician's scope of practice.